SCHEMBL18232135

SCHEMBL18232135

CC(=O)c1ccc(OC(C)C)c(N)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 1/20 0.61
POLB P06746 2/20 0.53
ALDH1A1 P00352 6/20 0.52
TSHR P16473 1/20 0.52
HTT P42858 2/20 0.50
LMNA P02545 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MEN1 O00255 1/20 0.50
PKM P14618 1/20 0.50
KMT2A Q03164 1/20 0.50
PRKCI P41743 1/20 0.49
MAPT P10636 2/20 0.48
TUBB4A P04350 1/20 0.46
TUBB P07437 1/20 0.46
TUBA3C P0DPH7 1/20 0.46
TUBA1B P68363 1/20 0.46
TUBA4A P68366 1/20 0.46
TUBB4B P68371 1/20 0.46
TUBB3 Q13509 1/20 0.46
TUBB2A Q13885 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31510251 1.00 CREBBP (0.61) CREBBPPOLBALDH1A1TSHRHTT
SCHEMBL6112896 0.86 PARP10 (0.56) CREBBPPOLBALDH1A1HTTLMNA
SCHEMBL10304691 0.86 KMT2A (0.53) CREBBPPOLBALDH1A1TSHRHTT
SCHEMBL1788246 0.83 USP2 (0.61) POLBALDH1A1HTTLMNAL3MBTL1
SCHEMBL6114150 0.83 CA12 (0.54) CREBBPPOLBALDH1A1HTTLMNA
SCHEMBL23118051 0.82 ALDH1A1 (0.46) CREBBPPOLBALDH1A1TSHRHTT
SCHEMBL2630553 0.82 EP300 (0.50) CREBBPPOLBALDH1A1HTTLMNA
SCHEMBL16924940 0.81 MLYCD (0.46) CREBBPPOLBALDH1A1HTTLMNA
SCHEMBL31439474 0.81 ALDH1A1 (0.49) CREBBPPOLBALDH1A1HTTLMNA
SCHEMBL16924924 0.81 USP2 (0.45) CREBBPPOLBALDH1A1TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9938245-B2 Carbonyl erastin analogs and their use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2018-04-10 US disclosed
US-9938245-B2 Carbonyl erastin analogs and their use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2018-04-10 US disclosed
US-20160332974-A1 CARBONYL ERASTIN ANALOGS AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2016-11-17 US disclosed
US-20160332974-A1 CARBONYL ERASTIN ANALOGS AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2016-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160332974-A1 CARBONYL ERASTIN ANALOGS AND THEIR USE KEAP1, GPX1, GPX4 CREBBP 585/4885POLB 4261/4885ALDH1A1 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.